Literature DB >> 22943552

A case of acute liver failure due to etodolac.

Fotios Sampaziotis, Rebecca J Brais, William J H Griffiths.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 22943552      PMCID： PMC3612737          DOI： 10.1111/j.1365-2125.2012.04448.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  [Acute hepatitis associated with etodolac therapy].

Authors:  J P Latrive; D Combaux; P Crépin; J C Barbare
Journal:  Therapie       Date:  1992 Jan-Feb       Impact factor: 2.070

2.  Effects of etodolac on P450 isoform-specific activities in human hepatic microsomes.

Authors:  Akio Nakamura; Katsuhiko Tougou; Hiroko Kitazumi; Tetsuhiro Yamada; Kumiko Honjou; Asumi Zinno; Kiyoko Nonaka; Hideya Mukai
Journal:  Arzneimittelforschung       Date:  2005

3.  An updated safety profile of etodolac in several thousand patients.

Authors:  M Schattenkirchner
Journal:  Eur J Rheumatol Inflamm       Date:  1990

Review 4.  Mechanisms of drug-induced liver injury: from bedside to bench.

Authors:  Shannan Tujios; Robert J Fontana
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03-08       Impact factor: 46.802

5.  A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury.

Authors:  Jonathan B Singer; Steve Lewitzky; Elisabeth Leroy; Fan Yang; Xiaojun Zhao; Lloyd Klickstein; Timothy M Wright; Joanne Meyer; Charles A Paulding
Journal:  Nat Genet       Date:  2010-07-18       Impact factor: 38.330

6.  Fulminant hepatic failure associated with etodolac use.

Authors:  C L Mabee; S W Mabee; P B Baker; R B Kirkpatrick; E J Levine
Journal:  Am J Gastroenterol       Date:  1995-04       Impact factor: 10.864
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.